Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF
Clinical trial NCT04824040 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04824040
- Sponsor
- Artgen Biotech
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-15
- Primary completion
- 2027-02-25
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.